MNMD
Price:
$7.56
Market Cap:
$554.39M
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.[Read more]
Industry
Biotechnology
IPO Date
2016-11-15
Stock Exchange
NASDAQ
Ticker
MNMD
According to Mind Medicine (MindMed) Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 283.41M. This represents a change of 52.95% compared to the average of 185.30M of the last 4 quarters.
The mean historical Enterprise Value of Mind Medicine (MindMed) Inc. over the last ten years is 127.90M. The current 283.41M Enterprise Value has changed 22.06% with respect to the historical average. Over the past ten years (40 quarters), MNMD's Enterprise Value was at its highest in in the June 2021 quarter at 1.24B. The Enterprise Value was at its lowest in in the December 2022 quarter at -58515900.80.
Average
127.90M
Median
314.03K
Minimum
-74183581.40
Maximum
731.88M
Discovering the peaks and valleys of Mind Medicine (MindMed) Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 293.18%
Maximum Annual Enterprise Value = 731.88M
Minimum Annual Increase = -177.84%
Minimum Annual Enterprise Value = -74183581.40
Year | Enterprise Value | Change |
---|---|---|
2023 | 57.74M | -177.84% |
2022 | -74183581.40 | -117.13% |
2021 | 433.17M | -40.81% |
2020 | 731.88M | 293.18% |
2019 | 249.55K | -20.53% |
2018 | 314.03K | -78.35% |
2017 | 1.45M | 456.00% |
2016 | 260.84K | -0.59% |
The current Enterprise Value of Mind Medicine (MindMed) Inc. (MNMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
138.91M
5-year avg
229.77M
10-year avg
127.90M
Mind Medicine (MindMed) Inc.’s Enterprise Value is greater than Cybin Inc. (120.27M), greater than Seelos Therapeutics, Inc. (10.08M), less than GH Research PLC (392.97M), greater than Awakn Life Sciences Corp. (4.81M), greater than Atai Life Sciences N.V. (264.01M), greater than Freeline Therapeutics Holdings plc (2.82M), greater than Bio-Path Holdings, Inc. (3.00M), greater than Vaccinex, Inc. (6.56M), greater than Eliem Therapeutics, Inc. (119.64M), less than Opthea Limited (514.42M), greater than Molecular Partners AG (132.68M), less than Edgewise Therapeutics, Inc. (3.01B), greater than iTeos Therapeutics, Inc. (185.75M), greater than Checkpoint Therapeutics, Inc. (175.79M), greater than Mustang Bio, Inc. (7.08M), greater than Reviva Pharmaceuticals Holdings, Inc. (33.37M), greater than Fortress Biotech, Inc. (57.12M), greater than Kodiak Sciences Inc. (201.31M),
Company | Enterprise Value | Market cap |
---|---|---|
120.27M | $196.32M | |
10.08M | $214.97K | |
392.97M | $482.30M | |
4.81M | $3.95M | |
264.01M | $270.16M | |
2.82M | $28.28M | |
3.00M | $3.53M | |
6.56M | $9.41M | |
119.64M | $342.68M | |
514.42M | $486.27M | |
132.68M | $219.11M | |
3.01B | $3.05B | |
185.75M | $303.96M | |
175.79M | $180.50M | |
7.08M | $9.63M | |
33.37M | $38.12M | |
57.12M | $44.44M | |
201.31M | $325.74M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mind Medicine (MindMed) Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Mind Medicine (MindMed) Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Mind Medicine (MindMed) Inc.'s Enterprise Value?
What is the highest Enterprise Value for Mind Medicine (MindMed) Inc. (MNMD)?
What is the 3-year average Enterprise Value for Mind Medicine (MindMed) Inc. (MNMD)?
What is the 5-year average Enterprise Value for Mind Medicine (MindMed) Inc. (MNMD)?
How does the current Enterprise Value for Mind Medicine (MindMed) Inc. (MNMD) compare to its historical average?